ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,049Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 278

$1.47M Total Retail Price of All Prescriptions

Rank: 8 out of 278

854 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 854 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 854 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 18,748 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 1,294 948 S3 1 1
LEVOTHYROXINE SODIUM 846 721 2 2
SIMVASTATIN 833 670 3 4
OMEPRAZOLE 731 621 4 3
AMLODIPINE BESYLATE 630 564 5 7
LISINOPRIL 595 490 6 5
FUROSEMIDE 553 436 7 6
METFORMIN HCL 466 409 8 8
METOPROLOL TARTRATE 403 359 9 9
GABAPENTIN 362 231 10 12
CRESTOR 310 236 11 19
NAMENDA 298 274 12 48
WARFARIN SODIUM 297 216 13 11
ATORVASTATIN CALCIUM 292 241 14 13
METOPROLOL SUCCINATE 291 229 15 10
ZOLPIDEM TARTRATE 280 162 16 26
CITALOPRAM HBR 264 228 17 21
ATENOLOL 259 230 18 18
SERTRALINE HCL 250 226 19 25
DONEPEZIL HCL 247 230 20 29
NEXIUM 245 131 21 14
TRAZODONE HCL 238 171 22 47
GLIMEPIRIDE 238 186 22 28
CLOPIDOGREL 233 202 24 20
CYMBALTA 232 110 25 41
POTASSIUM CHLORIDE 229 200 26 17
LYRICA 216 130 27 67
PRAVASTATIN SODIUM 214 195 28 16
LOSARTAN POTASSIUM 211 173 29 24
ALENDRONATE SODIUM 211 186 29 51
QUINAPRIL HCL 209 186 31 94
MIRTAZAPINE 209 160 31 61
TRIAMTERENE-HCTZ 183 157 33 58
LOSARTAN-HYDROCHLOROTHIAZIDE 183 147 33 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 181 140 35 31
KLOR-CON M20 180 144 36 42
KLOR-CON M10 176 132 37 90
CARVEDILOL 175 152 38 23
LANTUS 163 121 39 56
FLUTICASONE PROPIONATE 162 145 40 44
PANTOPRAZOLE SODIUM 158 114 41 36
DIGOXIN 157 131 42 40
PLAVIX 156 133 43 30
TRAMADOL HCL 139 105 44 22
AMLODIPINE BESYLATE-BENAZEPRIL 136 82 45 77
ESCITALOPRAM OXALATE 132 83 46 63
MELOXICAM 130 74 47 37
VYTORIN 116 110 48 148
DILTIAZEM 24HR ER 114 110 49 121
CYCLOBENZAPRINE HCL 109 50 R 50 78
RANITIDINE HCL 108 76 51 27
VENLAFAXINE HCL ER 107 58 52 126
ATENOLOL-CHLORTHALIDONE 107 105 52 220
HYDROCHLOROTHIAZIDE 104 85 54 15
DIVALPROEX SODIUM 103 67 55 103
EXELON 103 90 55 140
GLIPIZIDE 103 83 55 55
RISPERIDONE 102 102 58 79
TRAMADOL HCL-ACETAMINOPHEN 102 74 58 153
CLONIDINE HCL 100 99 60 50
TAMSULOSIN HCL 100 73 60 32
ALLOPURINOL 95 77 62 38
PAROXETINE HCL 95 65 62 57
JANUVIA 94 79 64 53
SPIRIVA 93 70 65 49
ZETIA 92 78 66 59
LANTUS SOLOSTAR 92 55 66 98
PROAIR HFA 90 73 68 34
ROPINIROLE HCL 88 69 69 69
AZITHROMYCIN 88 72 69 39
MORPHINE SULFATE ER 86 33 S2 71 150
NOVOLOG 84 47 72 122
ISOSORBIDE MONONITRATE ER 82 56 73 33
SINGULAIR 81 43 74 60
ACTOS 80 58 75 101
ADVAIR DISKUS 80 74 75 45
BENAZEPRIL HCL 79 71 77 108
OXYCODONE-ACETAMINOPHEN 77 33 S2 78 71
PEN NEEDLE 76 48 79 105
FENTANYL 76 58 S2 79 82
SYNTHROID 70 66 81 46
KLOR-CON 10 70 58 81 147
GLYBURIDE-METFORMIN HCL 69 43 R 83 159
BYSTOLIC 68 68 84 114
PROMETHAZINE HCL 67 36 R 85 106
AMITRIPTYLINE HCL 67 59 R 85 73
FENOFIBRATE 67 43 85 64
NYSTATIN 64 59 88 218
TRICOR 63 53 89 87
OXYCODONE HCL-ACETAMINOPHEN 62 39 S2 90 83
VITAMIN D2 61 48 91 168
LOVASTATIN 61 53 91 52
CIPROFLOXACIN HCL 61 50 91 65
QUETIAPINE FUMARATE 60 19 94 80
DIOVAN 60 50 94 43
INSULIN SYRINGE 60 32 94 72
DOXAZOSIN MESYLATE 58 55 97 131
CARBIDOPA-LEVODOPA 57 51 98 113
NOVOLIN 70-30 56 44 99 332
OXYBUTYNIN CHLORIDE ER 55 45 100 146
FLUDROCORTISONE ACETATE 55 49 100 282
MONTELUKAST SODIUM 53 39 102 96
FELODIPINE ER 52 50 103 112
PREDNISONE 52 45 103 35
CELEBREX 51 37 105 85
QUINAPRIL-HYDROCHLOROTHIAZIDE 50 50 106 244
ESTRADIOL 50 43 R 106 224
LORAZEPAM 50 42 106 204
DICLOFENAC SODIUM 50 37 106 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 21, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.